Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Tobacco Use Disorder
NCT03248713Phase 1Terminated
- Sponsor
- Yale University
- Start
- Nov 2017
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Mifepristone with Placebo (2 arms). Primary endpoint: Minnesota Nicotine Withdrawal Symptom Checklist at 1 week. Started Nov 2017; status: terminated.
02
Drugs
mifepristone
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT03248713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03248713.